Explore more publications!

Press Releases

Industry Analysis: Q-Switched Pico Laser Technology and Pigment Removal Applications from Huameilaser
Australian Landlords & Renters Struggling With Bill Comparisons
Industry Analysis: 5-in-1 HIFU Technology and China’s Export-Oriented Manufacturing Landscape
RNA Australia appoints experienced biotech leader as CEO
Industry Analysis: Multi-Functional IPL DPL Machine Technology and Its Impact on Clinic Operations
Expert team assembled to guide preventive health policy in South Australia

Expert team assembled to guide preventive health policy in South Australia

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
North American Construction Group Strengthens its Presence in Western Australia with the Acquisition of Iron Mine Contracting, a Diversified Mining Services Contractor
Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring
Genius Group Engages DLA Piper as Advisor on Australian Securities Exchange (ASX) Dual Listing.
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
Vehicle-to-Grid Technology Market Grows Rapidly as EV Adoption and Smart Grid Investments Accelerate Worldwide
Western Australia Grabbles with Bushfires

Western Australia Grabbles with Bushfires

Western Australia fights bushfires amid communication outage

Western Australia fights bushfires amid communication outage

Western Australia Struggles Against Severe Bushfire Crisis

Western Australia Struggles Against Severe Bushfire Crisis

Small UAV Market Projections 2025-2032: Key Trends, Opportunities, and Growth Factors in New Report | Bayer Tech, DJI
New Immunotherapy Trial for Advanced Melanoma Actively Recruiting Patients in Queensland, Australia.
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
The Conversation Article by Andrea Carter Gains Readership in Australia
J.P. Morgan Extends Global Research Leader Winning Streak

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions